General Summary of Position
About 2Bles Hematology/Oncology/BMT
2 Bles is an 18-bed, newly renovated, Hematology/Oncology/Blood and Marrow Transplant Unit. 2 Bles is one of two adult inpatient oncology units at MedStar Georgetown, caring for the patients of the Lombardi Comprehensive Cancer Center, established in 1971. Lombardi was initially designated by the National Cancer Institute (NCI) in 1974 and achieved NCI comprehensive status in 1990. The mission of Lombardi is to improve the diagnosis, treatment, and prevention of cancer through innovative basic science, clinical research, patient care, community outreach, and the training of cancer specialists of the future.
The patient population of 2 Bles includes all hematologic diseases and cancers (leukemia, lymphoma, multiple myeloma, ITP), autologous PBSC transplant patients, oncologic solid tumor, and a wide range of medical diagnoses. The nurses on 2 Bles provide expert care for their patients, often utilizing a number of hematology/oncology research protocols and CAR-T Cell Therapy. In the spring of 2013, MedStar Georgetown entered into an affiliation with Hackensack University Medical Center (HUMC) to establish a Blood and Marrow Stem Cell Transplantation Program. This agreement creates greater access to people with cancer, blood diseases and immune deficiency conditions to receive lifesaving treatment in the Washington, DC area. In 2016, the Blood and Marrow Stem Cell Transplantation Program received FACT accreditation for autologous transplants.
The incumbent in this position is a Department Leader who assumes 24 hour administrative authority and responsibility for the management and direction of the operational, personnel and financial activities of a specified unit or procedural area. These functions are coordinated with the Executive Staff, Hospital Leadership, Medical Staff and others and are performed in accordance with all applicable laws and regulations and MedStar Georgetown University Hospital's mission, vision and core values.